19 completed, 8 unknown, 6 recruiting, 5 withdrawn. 22 Not applicable, 10 Phase 2, 3 Phase 3, 3 Phase 4, 2 Phase 1.
Follow Insulin Infusion Systems: new trials by email Literature Review of Insulin Infusion Systems trials Research Report on Insulin Infusion Systems
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Postoperative Insulin Intervention After Pancreatectomy in nDM Patients Insulin Infusion, No Insulin Infusion (Standard Monitoring Only) - Postoperative Hyperglycemia, Pancreatectomy | Not applicable | Not yet recruiting | Dae Wook Hwang | 290 | 2026-05-18 | 2026-04-21 |
| Pilot Study of Intrapartum Insulin Pump Insulin pump - Diabetes, Diabetes (Insulin-requiring, Type 1 or Type 2) | Not applicable | Not yet recruiting | Medstar Health Research Institute | 30 | 2026-04-01 | 2026-02-19 |
| Physical Activity and Insulin Sensitivity Dynamics One-legged-knee extensor exercise, Insulin infusion, Muscle Biopsy Medication: Lidocaine - Insulin Sensitivity | Not applicable | Recruiting | University of Copenhagen | 8 | 2025-05-05 | 2025-12-02 |
| Evaluating an Insulin Pump for Time in Range (TIR) in Patients with Type 1 Diabetes insulin pump (model: AR-B200A) - Type 1 Diabetes Mellitus, Insulin Pump | Not applicable | Not yet recruiting | Tao Yuan,MD | 60 | 2024-12-11 | 2024-12-19 |
| Allo HSCT for High Risk Hemoglobinopathies Alemtuzumab, Total Body Irradiation, Cell Infusion - Graft Failure, Sickle Cell Disease | Phase 2 | Recruiting | Masonic Cancer Center, University of Minnesota | 62 | 2024-11-19 | 2026-06-04 |
| MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure. Rituximab, Rabbit ATG, Cyclophosphamide - Severe Aplastic Anemia, Acquired Amegakaryocytic Thrombocytopenia | Phase 2 | Recruiting | Masonic Cancer Center, University of Minnesota | 60 | 2024-06-05 | 2026-06-03 |
| Automated Insulin Delivery vs. Injections: Sleep Impact in Pediatric Type 1 Diabetes Insulin pump - Type1diabetes | Unknown | Oregon Health and Science University | 80 | 2024-05-15 | 2024-04-04 | |
| T1D Closed-loop and Physical Activity Type 1 diabetes with insulin infusion system - Diabetes type1 | Unknown | Centre Hospitalier Universitaire de Nice | 65 | 2024-05-06 | 2024-06-14 | |
| ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells Chemotherapy, Cell infusion - Hodgkin Lymphoma, Relapse | Phase 1 / Phase 2 | Recruiting | UNC Lineberger Comprehensive Cancer Center | 31 | 2024-04-25 | 2026-08-06 |
| Hybrid Closed-loop Insulin Delivery System in Perioperative Diabetic Patients: an Open-label, Randomized Controlled Trial Hybrid Closed-loop Insulin Delivery System, Insulin pump - Diabetes Mellitus | Not applicable | Completed | Huazhong University of Science and Technology | 54 | 2023-10-16 | 2025-05-23 |
| mTOR as Mediator of Insulin Sensitivity Study Exercise, Insulin infusion, Placebo - Insulin Sensitivity | Not applicable | Recruiting | University of Copenhagen | 10 | 2022-02-10 | 2024-05-16 |
| The SMART B Exercise Study :''The SMART Study'' Insulin pump - Hypoglycemia | Not applicable | Completed | Steno Diabetes Center Copenhagen | 11 | 2021-09-14 | 2022-11-10 |
| Clinical Efficacy of Insulin Pumps in Type 1 Diabetes Mellitus Patients in Spain Insulin pump - Type 1 Diabetes | Completed | Castilla-La Mancha Health Service | 2977 | 2021-09-01 | 2022-02-09 | |
| Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes Stepped hyperinsulinaemic-hypoglycaemic clamp study, Insulin pump, Continuous glucose monitor - Type 1 Diabetes, Type 1 Diabetes Mellitus With Hypoglycemia | Not applicable | Completed | University of Edinburgh | 24 | 2021-07-26 | 2026-01-28 |
| Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels Single-hormone closed-loop system, Insulin pump, Continuous glucose monitoring system - Type 1 Diabetes | Not applicable | Completed | Institut de Recherches Cliniques de Montreal | 30 | 2020-07-10 | 2022-01-28 |
| Faster Aspart on Insulin-pump Treated T1DM Patients Insulin Faster Aspart, Insulin pump - Type 1 Diabetes | Completed | Jesús Moreno Fernández | 48 | 2020-01-31 | 2021-02-01 | |
| Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 Diabetes 12-day intervention with sensor-augmented pump therapy, 12-day intervention with single-hormone closed-loop strategy, Insulin pump - Type 1 Diabetes | Phase 2 | Completed | Institut de Recherches Cliniques de Montreal | 36 | 2019-01-24 | 2020-06-11 |
| HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma cell infusion - Kidney Cancer | Phase 1 | Active not recruiting | National Heart, Lung, and Blood Institute (NHLBI) | 17 | 2018-07-20 | 2026-04-28 |
| Insulin-based Strategies to Prevent Hypoglycemia During Exercise Exercise 1, Exercise 2, Dexcom G4 Platinum - Type 1 Diabetes Mellitus | Not applicable | Unknown | McGill University Health Centre/Research Institute of the McGill University Health Centre | 20 | 2018-05-18 | 2018-05-22 |
| Comparison of the Efficacy of Rapid-acting Aspart and Faster Acting Aspart Within the Context of Single-hormone Closed-loop Strategy at Regulating Postprandial Glucose Levels Insulin pump, Continuous glucose monitoring system, 11-hour intervention with the single-hormone artificial pancreas - Type 1 Diabetes Mellitus | Phase 2 | Withdrawn | Institut de Recherches Cliniques de Montreal | 2018-04-01 | 2018-04-27 |
Showing 20 of 47. Sign in to see all of them.
Diabetes Mellitus, Type 1 (21) · Insulin Resistance (12) · Hypoglycemia (7) · Diabetes Mellitus (6) · Motor Activity (5) · Diabetes Mellitus, Type 2 (3) · Pain (2) · Acquired amegakaryocytic thrombocytopenia (1) · Agnosia (1) · Anemia, Aplastic (1) · Anemia, Sickle Cell (1) · Cardiovascular Diseases (1) · Chronic Pain (1) · Colorectal Neoplasms (1) · Diabetic Nephropathies (1)
Institut de Recherches Cliniques de Montreal (6) · Glostrup University Hospital, Copenhagen (2) · Masonic Cancer Center, University of Minnesota (2) · Medtronic MiniMed, Inc. (2) · Piramal Critical Care, Ltd. (2) · Providence Health & Services (2) · University of Copenhagen (2) · Arizona State University (1) · Castilla-La Mancha Health Service (1) · Centre Hospitalier Universitaire de Nice (1) · Chinese PLA General Hospital (1) · Clinical Research Centre, Malaysia (1) · Dae Wook Hwang (1) · Huazhong University of Science and Technology (1) · IKFE Institute for Clinical Research and Development (1)
United States (14) · Canada (6) · Denmark (5) · China (2) · France (2) · Israel (2) · South Korea (2) · Spain (2) · Germany (1) · Italy (1) · Japan (1) · Malaysia (1) · Singapore (1) · Sweden (1) · United Kingdom (1)
Binbin Zheng, MD (1) · Dae Wook Hwang (1) · Dana S Hardin, MD (1) · David M Thompson, MD (1) · Francis J Doyle, PhD (1) · Howard Zisser, MD (1) · Irwani Ibrahim, MBBS (1) · Isabelle Guilhem (1) · Jay S. Skyler, M.D., M.A.C.P. (1) · Jose Alberto Garcia Seco, RN (1) · Katherine Esposito (1)
PMID 23570538, PMID 24471561, PMID 24623024, PMID 26902791, PMID 28134564, PMID 29148821, PMID 29433562, PMID 30585770, PMID 31099946, PMID 32740723, PMID 33050728, PMID 35001477, PMID 35099281, PMID 35947087, PMID 36399114, PMID 36482870, PMID 36600427, PMID 36724311, PMID 37356876, PMID 39266213